Patients, providers, and policy-makers came together from across Canada came together in March to plant, cultivate, and nurture support for new randomized controlled trials in hemodialysis.

The Gardener’s Grove Conference 2023 was a four-day virtual event featuring education sessions and presentations of proposed pragmatic trials that have the potential of improving routine hemodialysis care. Audience participation, group discussions and expert panels provided meaningful advice to improve the proposed trials and nurture new ideas.

The Canadian Nephrology Trials Network (CNTN) was well represented at the conference with presentations by four committee members.

  • Karthik Tennankore: BP in HD: Finding the Right Blood Pressure Target for Patients on Dialysis (View video)
  • Melissa Schorr: Impact of diuretic use on Cardiovascular Outcomes and Mortality in Patients on Maintenance Hemodialysis Who Have Residual Renal Function (View video)
  • Amber Molnar and Dr. Samuel Silver: Dial-Bicarb – Outcomes of a Higher vs. Lower Hemodialysate Bicarbonate Concentration (View video)

A detailed summary of the conference, including all presentations and panel discussions, can be viewed here.